Aurobindo Pharma receives USFDA approval for valganciclovir
Aurobindo Pharma has received final USFDA approval to manufacture and market valganciclovir tablets USP, 450 mg. This product is to be launched in Q1 FY16-17. […]
Aurobindo Pharma has received final USFDA approval to manufacture and market valganciclovir tablets USP, 450 mg. This product is to be launched in Q1 FY16-17. […]
Cadila Healthcare has received USFDA approval for its anti-viral generic drug Acyclovir capsules Acyclovir capsules to market the same in the American market. The drug […]
Nesher Pharmaceuticals, an arm of Zydus Pharmaceuticals USA has received its first Abbreviated New Drug Application (ANDA) approval from the US FDA to market Dextroamphetamine […]
Aurobindo Pharma has received final USFDA approval to manufacture and market Levofloxacin injection, an anti-infective used in the treatment of bacterial infection in adults in […]
Dr. Reddys Laboratories through its subsidiary Promius Pharma has received USFDA approval to market Sernivo spray, used in treatment of skin disorder. The drug Sernivo […]
Aurobindo Pharma has received final USFDA approval to manufacture and market pre- surgery sedation injections Dexmedetomidine Hydrochloride in 200 mcg (base)/2 mL (100 mcg (base)/mL) […]
Orchid Pharma has received final USFDA approval for its generic version of rasagiline tablets used in the treatment of Parkinson’s disease. The company expects to […]
Glenmark Pharmaceuticals has received the final USFDA approval for its generic oral contraceptive norgestimate ethinyl estradiol tablets. in strengths of 0.18 mg/0.025 mg, 0.215 mg/ […]
Zydus Cadila has received final USFDA approval to sell anti-diabetics Glyburide and Metformin Hcl tablets in in strengths of 1.25/250, 2.5/500 and 5/500 mg in […]
Ajanta Pharma has received final USFDA approval for its generic version of acute migraine pain relief drug almotriptan malate tablets . The company will produce […]
Copyright © 2024 | WordPress Theme by MH Themes